ESR1 and breast carcinoma: We first investigated the effect of TJ-41 on the growth of estrogen receptor positive (MCF-7) and estrogen receptor negative (MDA-MB-231) breast cancer cell lines in vitro by measuring 3H-Thymidine incorporation.